💨
Halitosis — Assessment & Management UK primary care pathway · RCGP SCA preparation · Oral, ENT & systemic causes
Progress 0 / 9

⚡ Snapshot. The whole pathway on one page: act now, triage, classify, treat today and safety-net. The Steps tab holds the detail.

Open full screen ↗
1
Safety

Red Flags — Screen for Serious Underlying Pathology

Most halitosis is benign and oral in origin. Red flags are identified during assessment of a patient who happens to report halitosis — halitosis alone does not meet a suspected cancer referral criterion. Use the appropriate local cancer, ENT, dental or emergency pathway.

Oropharyngeal / oral cancer Unexplained oral ulceration >3 weeks or persistent unexplained neck lump → consider Suspected cancer pathway · head & neck (NICE NG12). Aged 45 and over with persistent unexplained hoarseness → consider suspected cancer pathway referral for laryngeal cancer (NICE NG12). Trismus, unilateral otalgia with normal otoscopy, odynophagia or neck nodes → local head-and-neck pathway. Lip/oral cavity lump or red or red-and-white patch → Urgent dental assessment (onward referral per dentist and local pathway).
Lung abscess / bronchiectasis Foul, sweet, or faeculent breath + chronic productive cough, haemoptysis, fever, weight loss → Respiratory examination + targeted imaging/referral; same-day if systemically unwell Unexplained haemoptysis aged 40 and over → suspected lung cancer pathway referral (NICE NG12).
Oesophageal pathology Regurgitation of undigested food (Zenker's diverticulum) or any dysphagia (difficulty swallowing) → Upper GI suspected cancer pathway referral (NICE NG12 (updated April 2026))
Diabetic ketoacidosis (DKA) Fruity/ketotic breath + nausea, vomiting, Kussmaul breathing, confusion, known/undiagnosed diabetes → Immediate capillary glucose + blood ketones; suspected DKA → immediate hospital admission (999 if confused, drowsy or Kussmaul breathing)
Uraemic fetor Fishy/ammonia breath + uraemic symptoms (fatigue, itching, oedema), known CKD or risk factors → Assess clinically; renal function, electrolytes ± acid–base status. Admit/refer per AKI, electrolyte disturbance, severe uraemic symptoms or instability — not on odour alone
Hepatic fetor Musty/sweet "fetor hepaticus" + jaundice, confusion, bleeding tendency, known liver disease → Same-day ED if encephalopathy
Airway / deep neck infection Stridor, drooling or inability to swallow secretions → 999. Suspected quinsy or deep neck infection, severe systemic illness → Same-day emergency assessment (ENT/ED)
Nasal foreign body (child) Unilateral foul-smelling nasal discharge in child → Same-day ENT or ED (child) for removal
Pseudohalitosis / halitophobia Patient convinced of halitosis despite others not noticing, significant distress, social withdrawal → Assess first; consider health anxiety, OCD, social anxiety or body dysmorphic symptoms — NHS Talking Therapies where appropriate
Head and neck cancers have a much better outlook when diagnosed early — the suspected cancer pathway exists to capture patients with NICE NG12 features (unexplained oral ulceration >3 weeks, persistent unexplained neck lump), not halitosis alone. Lung abscess and bronchiectasis are associated with characteristic halitosis (volatile sulfur compounds + anaerobic bacteria) that is qualitatively distinct from oral halitosis. DKA and hepatic encephalopathy are life-threatening metabolic emergencies that may be accompanied by characteristic breath odours; the clinical features, not the odour alone, drive urgent assessment. Nasal foreign bodies in children are commonly missed and cause significant morbidity from chronic infection.
2
Diagnose

History — Characterise the Halitosis & Identify Source

Most persistent halitosis is oral in origin, commonly related to tongue coating, gingivitis, periodontitis, dental disease, dentures or xerostomia; extra-oral causes are less common — identify oral vs extraoral source with targeted history.

Duration & onset
Acute → infection (tonsillitis, abscess, sinusitis), DKA. Chronic (>3 months) → gum disease, tongue coating, chronic rhinosinusitis, GI pathology.
Quality of odour
Rotting/sulphurous → periodontal / tongue coating (VSC). Fruity/sweet → DKA (ketones). Faeculent → anaerobic lung infection, GI. Fishy/ammonia → uraemia. Musty → hepatic fetor.
Oral hygiene
Brushing frequency, flossing, tongue brushing, dental attendance, denture care, orthodontic appliances. Last dental visit? Bleeding gums or other periodontal symptoms?
ENT symptoms
Postnasal drip, chronic nasal congestion, nasal polyps, recurrent sinusitis → posterior nasal/sinus source. Mouth breathing worsens oral halitosis.
GI symptoms
Heartburn, regurgitation, dyspepsia, dysphagia → consider GORD/dyspepsia or Zenker's diverticulum only with a compatible symptom pattern. The causal link between GORD and halitosis is uncertain despite common patient belief.
Medications
Review for xerostomia-causing drugs (tricyclics, antihistamines, diuretics, ACE inhibitors, antipsychotics). Also: metronidazole (metallic taste), disulfiram, dimethyl sulfoxide.
Social history
Smoking (worsens VSC production), alcohol (dehydrates oral mucosa + acetaldehyde), dietary factors (garlic, onions, cruciferous vegetables — transient halitosis).
Impact on life
Assess social functioning, relationship impact, anxiety level. Has an independent observer noticed the odour? Has a professional confirmed it? Consider possible pseudohalitosis/halitophobia.
Most persistent halitosis originates intraorally — primarily volatile sulfur compounds (VSCs: hydrogen sulfide, methyl mercaptan) produced by anaerobic gram-negative bacteria on the tongue dorsum and in periodontal pockets. The quality of breath odour may point towards a cause but is not diagnostic on its own — interpret it with the history and examination. The evidence on prevalence, source and treatment effect sizes is heterogeneous, so avoid precise percentages.
3
Diagnose

Classification — Identify the Aetiology

Classify by anatomical origin to direct appropriate referral and treatment.

Genuine oral halitosis (most common)
Tongue coating (most common), periodontal disease, caries, poorly fitting dentures, dry mouth (xerostomia), oral infections. Primary VSC producers. Dental assessment and treatment
Physiological halitosis
Morning breath (reduced saliva flow overnight), dietary (garlic, onions, spices), fasting state (ketones), smoking. Benign, temporary. No treatment beyond hygiene. Lifestyle advice
ENT-origin (less common)
Chronic rhinosinusitis, nasal polyps, postnasal drip, tonsil crypts (tonsilloliths), foreign body, persistent unilateral nasal disease, peritonsillar abscess, nasopharyngeal pathology. Treat per ENT/primary-care pathway; refer if persistent, unilateral, complicated or atypical
Respiratory origin
Bronchiectasis, lung abscess, empyema, active TB. Consider with chronic productive cough, recurrent infections, haemoptysis, bronchiectasis or suspected lung abscess. Rare but important. Respiratory examination + targeted imaging/referral
GI origin (rare)
GORD (controversial link), Zenker's diverticulum (undigested food regurgitation), H. pylori (weak evidence for direct halitosis). Do not assume GORD. Follow NICE dyspepsia/GORD and suspected cancer guidance if compatible symptoms
Metabolic / systemic
DKA (fruity), uraemia (fishy/ammonia), hepatic failure (musty fetor hepaticus), trimethylaminuria (TMAU – fishy odour). Consider only when the odour is accompanied by compatible clinical features. Urgent targeted assessment if DKA/renal failure suspected
Pseudohalitosis
Patient conviction not confirmed by objective assessment (organoleptic or instrument measurement). No true malodour after a credible oral and basic ENT assessment. Explanation, validate distress, avoid repeated tests/mouthwash courses/referrals; NHS Talking Therapies where appropriate
Halitophobia
Persistent concern despite reassurance and normal assessment, socially impairing. Consider health anxiety, obsessive-compulsive, social anxiety or body dysmorphic symptoms. NHS Talking Therapies; secondary mental health if severe impairment, fixed delusional conviction, risk or diagnostic uncertainty
Classification prevents unnecessary GI investigation — many patients believe their halitosis is GI in origin, but the causal link with GORD is uncertain. Directing patients with genuine oral halitosis to dental assessment and treatment is more effective than prescribing mouthwashes in primary care. Tonsilloliths are usually benign and frequently overlooked; tonsillectomy should not be offered solely for halitosis without careful ENT assessment. Trimethylaminuria (TMAU) is rare; consider specialist advice only for persistent characteristic fish odour with normal oral and ENT assessment and no dietary/drug explanation.
4
Diagnose

Targeted Examination — Oral, ENT & Systemic

A focused examination localises the source in most cases. Avoid assessing immediately after smoking, strongly flavoured food, alcohol or fragranced products.

Organoleptic assessment
If appropriate, a simple mouth-versus-nose exhalation comparison — nasal source more likely if nasal exhalation is worse. Formal scales (e.g. Rosenberg 0–5) and halitometry are not routine validated primary-care practice. If no malodour is detected and examination is normal, consider pseudohalitosis/halitophobia.
Tongue inspection
Tongue coating on the dorsum — a common oral source. A tongue depressor may help but is not always needed.
Periodontal / dental
Bleeding on probing, gingival recession, obvious caries, abscess, food trapping sites, calculus. Note presence of prosthetics (dentures, implants, orthodontics).
Oral mucosa & salivary flow
Dry mucosa, sticky saliva, furrowed tongue → xerostomia. Assess salivary pooling under tongue. Frothy saliva = dehydration. Assess lips for mouth-breathing signs (dry, cracked). Inspect oral mucosa for ulcers, red/white lesions and masses.
Tonsils
Tonsil crypts with white debris (tonsilloliths), tonsillar hypertrophy, peritonsillar asymmetry, exudate. Tonsilloliths are VSC-producing bacterial deposits.
Nasal examination
Where clinically appropriate: anterior rhinoscopy — polyps, septal deviation, mucopurulent discharge, foreign body (child). Postnasal drip visible on posterior pharynx (cobblestoning).
Neck & systemic examination
Neck and cervical lymph nodes. General and systemic examination only where indicated: jaundice, uraemic skin changes (scratch marks), signs of DM (acanthosis nigricans). Respiratory: clubbing, crepitations. Lymphadenopathy (malignancy, HIV).
Mental state
If pseudohalitosis suspected — assess for health anxiety, obsessive-compulsive, social anxiety or body dysmorphic symptoms. PHQ-9/GAD-7 may help describe distress but are not referral criteria.
Organoleptic assessment (clinical smell rating) is the practical approach; formal halitometry and gas chromatography (OralChroma) are specialist tools, not routine general practice. Comparing oral vs nasal exhalation can help distinguish an oral from a nasal/sinus source. Tongue coating is a common, treatable finding (gentle tongue cleaning and improved hygiene), but it is one part of a full oral, dental, tonsillar and neck examination.
5
Diagnose

Investigations — Targeted, Not Routine

Most halitosis requires no investigation. Investigate only if systemic/ENT/GI cause is suspected.

Glucose / ketones
Fruity breath with symptoms suggesting DKA (vomiting, confusion, dehydration) → immediate capillary glucose + blood ketones + urgent clinical assessment. HbA1c is not an acute test for DKA — consider it only for suspected undiagnosed diabetes without acute features.
U&E / eGFR
If uraemia is clinically suspected, assess the patient and obtain renal function, electrolytes ± acid–base status as appropriate. Urgency depends on the clinical condition, not a single urea value.
LFTs / coagulation
Not solely for halitosis or a "musty" odour. LFTs, albumin, INR only if clinical features suggest liver disease (jaundice, ascites, bleeding, confusion, hepatomegaly) or relevant risk factors.
CXR
Chest X-ray — not for halitosis alone; only with respiratory symptoms/signs or a credible respiratory source (chronic productive cough, recurrent pneumonia, haemoptysis, bronchiectasis, suspected lung abscess). Cavity, consolidation, bronchial thickening. Follow-up CT chest if CXR abnormal.
Nasal endoscopy
Flexible nasendoscopy — via ENT if chronic rhinosinusitis not responding to treatment, polyps, nasopharyngeal pathology suspected. Not a primary care test.
H. pylori test
Do not test for H. pylori solely because of halitosis. Test only if the patient has dyspepsia and meets the usual test-and-treat approach, with no indication for urgent endoscopy (NICE CG184). Stop PPIs for 2 weeks before testing; use a carbon-13 urea breath test or stool antigen test; do not rely on office-based serology.
TMAU testing
Not a routine GP investigation. Consider specialist (metabolic medicine) advice only for persistent characteristic fish odour with normal oral and ENT assessment and no dietary/drug explanation. Very rare.
Do NOT routinely order
Upper GI endoscopy, H. pylori testing, empirical PPI, blood tests, chest X-ray or imaging for halitosis alone; salivary gland scans; MRI head for halitosis
Blanket investigation of halitosis is not evidence-based and leads to unnecessary patient anxiety and healthcare cost. Most patients have oral halitosis that requires dental assessment, not blood tests. Investigation should be driven by the suspected systemic cause identified in the history and examination. H. pylori testing is not a routine halitosis investigation — the evidence for H. pylori as a direct cause of halitosis is weak, though treating confirmed infection may improve symptoms in patients with dyspepsia.
6
Refer

Referral Criteria — Dental, ENT, Gastro, Mental Health

999 / Same-day ED
Emergency 999: airway compromise, stridor, drooling or inability to swallow secretions; suspected DKA with confusion, drowsiness or Kussmaul breathing; nasal foreign body with airway compromise. Same-day ED / admission: suspected quinsy/deep neck infection; severe systemic illness; any other suspected DKA (immediate); severe hepatic encephalopathy; acutely unwell patient with possible renal failure
Head & neck
Urgent head-and-neck pathway Consider a suspected cancer pathway referral for unexplained oral ulceration lasting more than 3 weeks, or a persistent unexplained neck lump (NICE NG12, updated April 2026), and for laryngeal cancer if aged 45 and over with persistent unexplained hoarseness (NICE NG12); relevant suspicious oral lesion; other local head-and-neck red flags (e.g. unilateral otalgia with normal otoscopy, trismus, odynophagia) according to local pathway — these are not NG12 criteria. Halitosis alone does not meet a suspected cancer referral criterion.
Dentist (urgent assessment)
Urgent dental assessment Lump on the lip or in the oral cavity; red or red-and-white oral patch (NICE NG12) — onward referral per the dentist's assessment and local pathway; dental abscess or spreading odontogenic infection
Upper GI
Suspected cancer Dysphagia at any age (including regurgitation of undigested food), or aged 55 and over with weight loss plus upper abdominal pain, reflux or dyspepsia — urgent upper-GI suspected cancer pathway referral (NICE NG12, updated April 2026)
Dentist (primary pathway)
Dental assessment Persistent oral halitosis, periodontal symptoms, dental disease, dentures, or no recent dental review — dental examination, treatment of caries/periodontal disease/abscess, professional periodontal cleaning when indicated. Acute periodontal infection or pain with swelling: prompt dental review
ENT routine
Routine Chronic rhinosinusitis troublesome despite appropriate treatment per local pathway, suspected nasal polyps or unilateral disease, complications or concerning features; tonsilloliths with recurrent tonsillitis significantly affecting daily life (ENT assessment — not automatic surgery); Zenker's diverticulum (if dysphagia, upper-GI suspected cancer pathway first)
Respiratory
Urgent Suspected lung abscess, suspected bronchiectasis, haemoptysis — after respiratory examination and targeted imaging. Unexplained haemoptysis aged 40 and over → suspected lung cancer pathway referral (NICE NG12).
Mental health / NHS Talking Therapies
Routine No objective malodour after a credible oral and basic ENT assessment, with significant distress or functional impairment. NHS Talking Therapies (CBT or OCD pathway) where appropriate; secondary mental health services if severe functional impairment, fixed delusional conviction, risk or diagnostic uncertainty. PHQ-9/GAD-7 thresholds are not mandatory referral criteria.
Primary care manage
Physiological halitosis (dietary/morning), oral hygiene advice alongside dental assessment, GORD/dyspepsia only with compatible symptoms (not for isolated halitosis), H. pylori eradication only when testing is indicated for dyspepsia, xerostomia management
Oral cavity cancer has a much better outlook when diagnosed early — referral is triggered by the NICE NG12 features found on assessment, not by halitosis itself; keep urgent dental assessment and suspected cancer pathway referral separate. Zenker's diverticulum can cause severe aspiration pneumonia if undiagnosed — dysphagia with regurgitation of undigested food must not be dismissed as GORD. In halitophobia, validate the distress without confirming an unsubstantiated belief; reassurance alone is often insufficient, and CBT-based approaches may help. Avoid repeated tests, mouthwash courses or referrals when no objective malodour is present.
7
Treat

Treatment Pathway — Cause-Directed Management

Treat the identified cause. Dental assessment and treatment is the central intervention for oral halitosis. Do not prescribe systemic antibiotics for uncomplicated halitosis — treat a confirmed dental, ENT or systemic infection according to the local antimicrobial guideline. Check allergies, pregnancy and renal impairment before prescribing.

Oral halitosis (VSC)
Dental treatment + oral hygiene
Dental examination; treatment of caries, periodontal disease and abscess; professional periodontal cleaning when indicated. Twice-daily brushing with fluoride toothpaste, interdental cleaning, gentle tongue cleaning (may reduce coating and malodour — avoid vigorous scraping), denture cleaning and overnight removal, xerostomia management. Chlorhexidine only as a short adjunct in selected patients (see below).
Xerostomia
Saliva substitutes
Review and rationalise xerogenic medicines where clinically possible; regular water intake; sugar-free gum or lozenges if appropriate; avoid frequent sugary drinks and acidic products; saliva substitutes or moisturising gels; dental prevention (xerostomia increases caries risk). Consider Sjögren's or other systemic disease only when supported by symptoms/signs. Pilocarpine: usually specialist-led or per local formulary — cautions include asthma/significant COPD, uncontrolled cardiovascular disease, narrow-angle glaucoma, significant renal or hepatic impairment, cholinergic/anticholinergic interactions; adverse effects include sweating, GI upset, dizziness and bradycardia. Check product information before prescribing.
Chronic rhinosinusitis
Intranasal corticosteroid + saline irrigation (local pathway)
Treat chronic rhinosinusitis according to the local pathway: optimise intranasal corticosteroid technique and saline irrigation where appropriate. Halitosis alone is not an indication for antibiotics. Refer if troublesome despite appropriate treatment, nasal polyps or unilateral disease suspected, or complications/concerning features. Acute sinusitis is separate (NICE NG79): no antibiotic for symptoms of around 10 days or less; consider high-dose nasal corticosteroid for 14 days (age 12+) if around 10 days or more without improvement; antibiotics only in selected circumstances — phenoxymethylpenicillin first choice, doxycycline as alternative for penicillin allergy/intolerance in non-pregnant adults, co-amoxiclav if very unwell/high risk; follow the local antimicrobial guideline. Refer to hospital for orbital or intracranial complication red flags.
GORD-associated
Only with a compatible reflux/dyspepsia pattern
Halitosis alone is not an indication for an empirical PPI. Treat GORD only when there is a compatible symptom pattern and a clinical indication for acid suppression (NICE CG184 — e.g. 4-week full-dose PPI for dyspepsia). Review lifestyle (head of bed elevation, avoid late meals). If halitosis does not improve, do not continue the PPI for this reason — reassess oral, ENT and medication-related causes.
H. pylori confirmed (tested for dyspepsia)
Triple therapy per local guidance guideline
Do not treat H. pylori because of halitosis alone. PPI + amoxicillin + either clarithromycin or metronidazole for 7 days (NICE CG184), taking previous antibiotic exposure into account — avoid clarithromycin, metronidazole or quinolones if used in the previous year; check penicillin allergy carefully; follow the local antimicrobial guideline and local formulary. Retest selectively (e.g. after peptic ulcer disease or treatment failure), not routinely for isolated dyspepsia.
Tonsilloliths
Reassurance + cautious self-care
Tonsilloliths are usually benign. Avoid forceful instrumentation or sharp objects; water irrigation may cause trauma or bleeding — advise caution. Do not use chlorhexidine indefinitely. Tonsillectomy should not be offered solely for halitosis without careful ENT assessment and discussion of uncertain benefit and operative risks. Recurrent tonsillitis thresholds (ENT UK decision aid) are not specific to halitosis and are not an automatic indication for surgery — episodes should significantly affect daily life.
Mouthwash guidance (optional adjuncts — not a substitute for dental treatment)
SelectedChlorhexidine mouthwash — not a substitute for dental treatment or toothbrushing, and not routine for every patient. If used, a short course in selected patients, preferably following dental advice, per product instructions. Counsel about tooth/restoration staining, taste disturbance, mucosal irritation, possible parotid swelling, rare serious hypersensitivity/anaphylaxis, and separating use from toothbrushing where applicable.
OptionalCetylpyridinium chloride (CPC) mouthwash — optional adjunct, available over the counter.
OptionalZinc-containing mouthwash — optional adjunct; neutralises VSC chemically. A short adjunctive trial may be considered but should not replace dental treatment.

Next steps: see Sinusitis · GORD and acid reflux

Gentle tongue cleaning may reduce tongue coating and malodour; avoid claiming a fixed percentage reduction. Chlorhexidine reduces oral bacteria, but staining, taste disturbance, mucosal irritation and rare hypersensitivity mean it is not appropriate as long-term or routine therapy, and it must not substitute for dental treatment. Zinc compounds work by converting volatile hydrogen sulfide into insoluble zinc sulfide — this is a complementary mechanism to antibacterial agents and explains the additive benefit of zinc-containing products.
8
Lifestyle

Non-Pharmacological Interventions — The Foundation of Treatment

Tongue cleaning Clean the tongue gently once or twice daily with a scraper or brush — avoid vigorous scraping. May reduce tongue coating and malodour.
Dental hygiene optimisation Brush teeth 2× daily with fluoride toothpaste, floss or interdental brush daily, regular dental checks at the interval the dentist advises (NICE NG30). Treat all active caries and periodontal disease.
Hydration Encourage regular water intake. Saliva flow is the natural mouth cleanser — dehydration reduces flow. Chew sugar-free (xylitol) gum to stimulate salivary flow. Avoid excessive caffeine and alcohol.
Smoking cessation Smoking directly increases VSC levels, causes gum disease, and impairs immune response to oral bacteria. Refer to NHS Stop Smoking Service.
Dietary modification Garlic, raw onions and spices cause transient odour. Avoid frequent sugary drinks and acidic products (caries risk, especially with dry mouth).
Alcohol reduction Alcohol dehydrates oral mucosa, reduces saliva flow, and acetaldehyde is itself a malodour. No more than 14 units/week, spread over 3 or more days (UK Chief Medical Officers). Alcohol use disorder: AUDIT-C + FRAMES brief intervention if appropriate.
Denture care Remove and clean dentures daily and remove them overnight. Old/ill-fitting dentures harbour anaerobic bacteria — arrange dental review.
Nasal breathing / mouth breathing Address nasal obstruction causing mouth breathing (treat per local rhinosinusitis/rhinitis pathway). Mouth breathing worsens oral halitosis through mucosal drying.
Lifestyle interventions — particularly tongue scraping, optimal oral hygiene, and hydration — are the most effective long-term treatment for oral halitosis. Unlike mouthwashes, they address the cause (bacterial load on tongue + periodontal deposits) rather than temporarily masking symptoms. Smoking cessation is an important modifiable risk factor for both halitosis and periodontal disease. NICE NG30 supports twice-daily toothbrushing with fluoride toothpaste, interdental cleaning where appropriate, and personalised dental care.
9
Safety

Follow-Up, Monitoring & Safety-Netting

Review if
An identified treatable cause needs monitoring; symptoms persist after appropriate dental treatment; ENT or systemic symptoms develop; or significant anxiety or functional impairment. Confirm dental assessment attended. If a PPI was started for compatible reflux symptoms, do not continue it solely for halitosis. Chlorhexidine courses should be short.
Later review
Review rhinosinusitis treatment response per local pathway. H. pylori retest selectively (e.g. after peptic ulcer or treatment failure) per CG184/local. Pseudohalitosis — review anxiety and functional impact; avoid repeated tests and referrals.
3–6 months
Review chronic conditions associated with halitosis (DM glycaemia, CKD progression, Sjögren's). Mental health follow-up if halitophobia — has NHS Talking Therapies engagement occurred?
Safety-net same-day GP
New oral ulceration, neck swelling, difficulty swallowing, coughing blood, yellow eyes or skin, or a child with one-sided smelly nasal discharge — re-examine for head and neck cancer signs and the Step 1 red flags. Call 999: difficulty or noisy breathing, drooling or unable to swallow saliva; ketotic breath with vomiting, confusion, drowsiness or fast deep breathing. Same-day ED: severe one-sided throat pain with fever, trismus or neck swelling (possible quinsy).
Re-refer if
Dental treatment completed but halitosis persists → reassess the diagnosis (oral, ENT, medication-related causes) rather than automatically escalating to ENT after failed mouthwash treatment; refer to ENT if ENT features are persistent, unilateral, complicated or atypical. Psychiatric symptoms escalating → increase support. New constitutional symptoms (weight loss, night sweats) → assess and use the NICE NG12 route for the likely site.
Monitoring — xerostomia Rx
Pilocarpine usually specialist-led/per local formulary — follow product information for cautions and adverse effects. Review xerogenic medications regularly — can any be stopped/reduced/switched? Dental review at the recall interval the dentist advises (NICE NG30).
Patient resources
British Dental Association (bda.org), NHS Choices oral hygiene guidance, Halitosis UK charity (patient information). Reassure: halitosis is common and treatable — do not minimise the significant social impact.
Persistent halitosis after adequate oral hygiene optimisation and dental treatment always warrants reassessment of the diagnosis. Some cases labelled as "refractory oral halitosis" have an ENT cause (tonsilloliths, chronic sinusitis) or a medication-related cause that was initially missed. NICE CG184 does not advise routine retesting after H. pylori eradication; retest selectively. The psychological impact of halitosis can be significant — validating distress and offering NHS Talking Therapies referral where appropriate is part of holistic management.
Educational use only. NICE guidance below supports selected parts of this pathway only — none is a specific halitosis guideline. References: NICE NG12 Suspected cancer (updated April 2026) — oral, head-and-neck and upper-GI referral criteria; NICE CG184 GORD and dyspepsia — dyspepsia, H. pylori testing and eradication; NICE NG79 Sinusitis (acute): antimicrobial prescribing — acute sinusitis only; NICE NG30 Oral health promotion: general dental practice; the local area prescribing committee (APC) antimicrobial guidelines (current version — H. pylori and acute sinusitis); ENT UK: Making a decision about recurrent tonsillitis (2023); Aylikci & Colak review of halitosis diagnosis and management (J Nat Sci Biol Med 2013; international); British Dental Association guidance. Add relevant local dental, ENT, suspected cancer, antimicrobial and formulary pathways. Always adapt to individual patient context and local referral pathways.